North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

MDT I AARHUS Søren Laurberg Professor of Surgery Aarhus University Hospital Denmark.
CRITICAL APPRAISAL ON AN ARTICLE ABOUT PROGNOSIS
Evidence for adjuvant radiation therapy benefiting breast cancer patients with 1 to 3 positive lymph nodes treated with a modified radical mastectomy and.
Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers A Randomized Controlled Trial A randomized.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Colorectal NSSG Audit Day - Polyp Cancers Northumbria Healthcare NHS Trust Sarah Mills.
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
AUDIT OF COMPLIANCE WITH NHSCSP GUIDELINES REQUIRING MDT REVIEW OF ALL CERVICAL CANCER PATIENTS Dr. M Bhattacharjee Dr. A Mutton Dr. S Nagarajan.
National Oesophago–Gastric Cancer Audit Comparing local and national figures.
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.
Managing the patients experience of radical surgery with HIPEC for stage 4 colorectal disease Jackie Rodger Lead Colorectal Nurse Specialist Carol Baird.
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
Treatment of Early Malignant Rectal Polyp
Options for surgical trials in vulva cancer.
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
NORCCAG audit report 2011: mortality, survival and reconstructive rectal surgery David W Borowski for the members of the Northern Region Colorectal Cancer.
Northern Region Colorectal Cancer Audit (NORCCAG) Colorectal NSSG – Audit meeting 1 st April 2006 – 31 st July 2010 Dorothy Simms – Audit Co-ordinator.
Should colonoscopy be performed one year out from colorectal cancer resection? Alexandra Kent, Philip Thompson, Prof Alan Horgan, Mr Paul Hainsworth Newcastle.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
SPINDLE CELL SARCOMA OF BONE AN ASSESSMENT OF OUTCOME
A. MONTORI M.D. F.A.C.S. PROFESSOR OF SURGERY UNIVERSITY OF ROME “LA SAPIENZA” President of EAcSS HOW TO AVOID MAJOR SURGERY IN RECTAL CANCER MSO-MTCC.
Metabolic Syndrome and Recurrence within the 21-Gene Recurrence Score Assay Risk Categories in Lymph Node Negative Breast Cancer Lakhani A et al. Proc.
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
The Treatment of the Axilla in the North of England Cancer Network. Henry Cain ST7 North Tyneside.
Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:
Quantifying the Morbidity of the Unplanned Sarcoma Excision
Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age.
CR07 results and informed patient consent David Sebag-Montefiore Leeds Cancer Centre.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Prognosis of colon cancer compared with rectal cancer. Where lies the difference? Bjørn S. Nedrebø Stavanger University Hospital.
AUDIT OF DOWN-STAGING CHEMORADIATION FOR LOCALLY ADVANCED RECTAL CANCER DR J J NICOLL NORTH CUMBRIA UNIVERSITY HOSPITALS SEPTEMBER 2012.
A comparison of open vs laparoscopic emergency colonic surgery; short term results from a district general hospital. D Vijayanand, A Haq, D Roberts, &
Adjuvant High-Dose-Rate Brachytherapy Alone for Stage I/II Endometrial Adenocarcinoma using a 4-Gray versus 6-Gray Fractionation Scheme Marie Lynn Racine,
Stereotactic Ablative Body Radiotherapy for Non small cell lung cancer
Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.
Failure to appropriately screen women according to international guidelines– what are the consequences? Alison Johnston*, M Sugrue, S Curran Department.
Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,
J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.
The Royal Marsden Solitary fibrous tumours The outcomes of 106 patients illustrating the unpredictable biological behaviour N Alexander, K Thway, JM Thomas,
Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist,
BREAST BRACHYTHERAPY OUTCOMES EVALUATION Margaret Pierce DNP, APRN, BC University of Tennessee Knoxville, Tennessee.
Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
RECTAL CARCINOMA AND PREOPERATIVE MRI: USING A NATIONAL DATASET FOR REGIONAL AUDIT South West Cancer Intelligence Service J Weeks
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
PHASE II TRIAL OF HYPOFRACTIONATED BREAST IRRADIATION WITH VMAT-SIB TECHNIQUE: TOXICITY AND EARLY CLINICAL ASSESSMENT IN 270 PATIENTS F. De Rose¹, F. Alongi¹,
Henry H L Wu Year 4 Medical Student University of Manchester
Oesophago–Gastric Cancer Audit
Brain imaging prior to lung cancer resection
Is there need for Pelvic Floor Reconstruction after Abdominoperineal Resection/ Pelvic Exenteration (APER/PE)? A Saklani, N Marsden, M Davies, C Sekaran,
Operative Approach and
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative.
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
National Bowel Cancer Audit
Prognosis of younger patients in non-small cell lung cancer
But how to treat those with positive SLNB? Results and Discussion
Laparoscopic vs Open Colonic Surgery: Long Term Survival
SPECIMEN SONOGRAM - Procedure
M.Boal; J. Batt; P. Wilkerson; D.R. Titcomb
Dr Jessica Jenkins Consultant Oncologist
The STAR-TREC Trial SIV Presentation
Supplementary Table S2 Correlation between pre-operative plasma miR-451 or miR-486 concentrations and clinicopathologic features in gastric cancer patients.
Presentation transcript:

North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014

Aims Appraise the management of T1 rectal cancer within our local unit To ensure patients are being stratified according to risk and managed appropriately

Methods Retrospective audit of prospectively collected data MDT database searched for T1 rectal tumours Between September 2013 and August 2014 Management and outcome data collected from electronic records/case notes

Results 11 patients diagnosed with T1 rectal cancer 5 females, 6 males Mean age 66 years(range 51-88) 4 bowel screening patients, remainder referred as 2 week rule

Results

EMR 3 patients Histology showed adenocarcinoma ranging from a microscopic focus to 13mm Completely excised No further intervention

TREC trial 1 patient randomised to neo-adjuvant radiotherapy + TEMS TEMS converted to single incision laparoscopic anterior resection as resectoscope was unable to reach area Histopathology: 7mm, Grade 1, T1Sm3 adenocarcinoma within 37mm high grade TVA 0/19 nodes Completely excised

TEMS 2 patients underwent TEMS as definitive treatment 1 patient opted for radiotherapy following discussion regarding risk of recurrence PatientSize (mm) GradeStage after TEMS Lympho/ vascular invasion Completely excised Adjuvant therapy 1201pT1N0Sm1Yes None 2242pT1NxSm3Yes Radiotherapy

TEMS with subsequent radical surgery 2 patients underwent TEMS followed by radical surgery ( 1 anterior resection and 1 APER) PatientSize (mm) GradeStage after TEMS Lympho/ vascular invasion Residual tumour after RS LN status following RS 1272pT1NxSm1YesNo1/24 +ve 2202pT1N1Sm3YesNo1/20 +ve

Radical Surgery 3 patients went straight to radical surgery Preop staging Tumour Size (mm) GradePathological staging 1T2N1M031T1Sm1N0Lap anterior resection + ileostomy 2T1/T2N0M0123T1Sm2N1Lap anterior resection + ileostomy 3T2N0M0302T1Haggit4N0Lap APER

Conclusion Significant variation in management of T1 rectal cancer Potential for over/under treatment Require further studies to assess optimal management of these patients with early disease